Journal
BIOSENSORS & BIOELECTRONICS
Volume 103, Issue -, Pages 143-150Publisher
ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2017.12.036
Keywords
Methylglyoxal; Electrochemical biosensor; Vanadium pentoxide; Non-enzymatic detection; Blood Plasma
Categories
Funding
- Council of Scientific and Industrial Research [09/1095/0012/2016-EMR-I]
- Nano Mission Council [SR/NM/PG-16/2007]
- Department of Science & Technology, India [SR/FST/ETI-284/2011(C)]
Ask authors/readers for more resources
Methylglyoxal (MG) is a predominant precursor for advanced glycation end products (AGEs) due to its protein glycation reactions, which are the major causes of diabetic complications. MG is explored as a significant biomarker towards the prediction of diabetic complications. With this background, a non-enzymatic electrochemical biosensor has been developed to detect MG in human blood plasma samples. Microwave synthesized V2O5 nanoplates were used as interface material in the fabrication of modified gold (Au) working electrode for electrochemical MG biosensor. Orthorhombic crystal structured V2O5 with an oxidation state of +5 exhibited specific MG sensing performance. Cyclic voltammetry and amperometry studies confirmed the electrocatalytic nature of V2O5 nanoplates modified Au electrode in the detection of MG. Non-enzymatic V2O5 modified Au electrode showed a sensitivity of 4.519 mu A mu M-1 with a linear range of 3-30 mu M, limit of detection (LOD) of 0.24 mu M, limit of quantification (LOQ) of 0.80 mu M and a response time less than 8 s towards MG. The lifetime and percentage recovery of the sensor was found to be 25 days (90%) and 102.5-108.7% respectively.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available